Join an ICIS committee to be a part of building the scientific home for all things cytokine research related and determining the future direction of the Society.

My being involved with the society was considered a plus by NIH for my tenure and promotion. It demonstrated that I was involved with the international scientific community. 40 years later, it is still of value for new tenure tracks to demonstrate that they are not in a silo and are interacting with the broader scientific community.
Howard Young
Howard Young, PhD
Senior Investigator at the Center for Cancer Research, National Cancer Institute, NIH, Bethesda, USA Founder and Editor of -ICIS Signals+ Newsletter since 1994, 2021 ICIS Mentorship Award Winner, Past-President of the International Society for Interferon and Cytokine Research, Chair of the ICIS Membership & Communications Committee

Awards Committee

  • Judith Allen (Co-Chair, 2021-2026), University of Manchester, UK
  • Greg Sonnenberg (Co-Chair, 2025 – 2027), Weill Cornell Medical College, New York, USA
  • WanJun Chen, MD (2025 – 2028), National Institutes of Health, NIDCR, Bethesda, USA
  • Joanna Groom (2025 – 2028), The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
  • You-Me Kim (2025 – 2028), Korea Advanced Institute of Science and Technology (KAIST), Korea
  • Hong-Gee Lee (Standing Member), PBL Assay Science, USA
  • Elia Tait Wojno (2024 – 2026), University of Washington, USA  
  • Thomas A Wynn (Standing Member), Pfizer, USA
  • Hiroki Yoshida (2021 – 2026), Saga University, Japan
  • Stephanie Flores, (ex-officio), ICIS Managing Director, San Francisco, USA

Nominations Committee

  • Claudia Nold (Chair, 2024 – 2026), Hudson Institute of Medical Research, Melbourne, Australia  
  • Ana Gamero (2024 – 2026), Lewis Katz School of Medicine, Temple University, Philadelphia, USA
  • Rune Hartmann (2022 – 2027), Aarhus University, Aarhus, Denmark
  • Ekaterina Koltsova (2024 – 2026), Cedars-Sinai Medical Center, Los Angeles, USA 
  • Lydia Lynch (2022 – 2027), Princeton University, Princeton, USA
  • Shruti Naik (2023 – 2025), New York University, New York, USA
  • Andreas Wack (2024 – 2026), Francis Crick Institute, London, UK
  • Stephanie Flores (ex-officio), ICIS Co-Managing Director, San Francisco, USA

Finance Committee

  • Dusan Bogunovic (Treasurer and Chair, 2019 – 2025), Icahn School of Medicine at Mount Sinai, USA
  • Kate Jeffrey (2024 – 2026), Moderna, USA 
  • Karen Mossman (2024 – 2026), McMaster University, Canada
  • Chris Hunter (2022 – 2024), University of Pennsylvania School of Veterinary Medicine, USA 
  • Stephanie Flores (ex-officio), ICIS Managing Director, San Francisco, USA

Early Career Researcher Committee

  • Adriana Forero, Co-Chair, (through 2026), The Ohio State University, College of Medicine, USA 
  • Juan Mendoza, Co-Chair, (through 2026) The University of Chicago, USA
  • Rami Bechara,* University of Paris-Saclay, INSERM, France
  • Ruby Dawson,* South Australian immuno-GENomics Cancer Institute, The University of Adelaide, Australia
  • Kellie Ann Jurado, Perelman School of Medicine, University of Pennsylvania, USA
  • Kevin Lee, Royal Melbourne Hospital, University of Melbourne, Australia
  • Ji Eun Oh, Korea Advanced Institute of Science and Technology (KAIST), Korea
  • Stephanie Flores, (ex-officio), ICIS Managing Director, San Francisco, USA

*ICIS Council members for Inclusion and Training

 

Development Committee

  • David Artis (Standing ICIS Development Officer), Weill Cornell Medicine, USA
  • Eleanor Fish (Standing Member), University Health Network Dept of Cell & Molecular Biology, Canada
  • Christopher Hunter (Standing Member), University of Pennsylvania School of Veterinary Medicine, USA
  • Luke O’Neill (Standing Member), Trinity College Dublin, Ireland
  • You-Me Kim (Cytokines 2024 Korea Meeting Chair), Korea Advanced Institute of Science and Technology (KAIST), Korea
  • Michael Gale, Jr. (Cytokines 2025 Seattle Meeting Co-Chair), University of Washington, USA
  • Ram Savan (Cytokines 2025 Seattle Meeting Co-Chair), University of Washington, USA
  • Simon Jones (Cytokines 2026 Glasgow Meeting Chair), Cardiff University, Wales
  • Phil Hansbro (Cytokines 2027 Sidney Meeting Chair), Centenary UTS Centre for Inflammation, Camperdown, AU
  • Ivan Zanoni (Cytokines 2028 Boston Meeting Chair), Boston Children’s Hospital, USA
  • Stephanie Flores, (ex-officio), ICIS Managing Director, San Francisco, USA

Meetings Committee

  • Brendan Jenkins (Chair 2017-2025), University of Adelaide, Australia
  • Adriana Forero, Co-Chair, (2025-2028), The Ohio State University, College of Medicine, USA 
  • Michael Gale, Jr.* (Cytokines 2025 Seattle Meeting Co-Chair), University of Washington, USA
  • Adolfo Garcia-Sastre* (Cytokines 2029 Salamanca Meeting Co-Chair), Icahn School of Medicine, New York, USA
  • Phil Hansbro* (Cytokines 2027 Sidney Meeting Chair), Centenary UTS Centre for Inflammation, Camperdown, AU
  • Curt Horvath (2014-2025), Northwestern University, USA
  • Simon Jones (Cytokines 2026 Glasgow Meeting Chair), University of Cardiff, UK
  • Kellie Jurado (2023-2026), University of Pennsylvania, USA
  • You-Me Kim (2025 – 2028), Korea Advanced Institute of Science and Technology (KAIST), Korea
  • Ignicio Moraga* (Cytokines 2029 Salamanca Meeting Co-Chair), Dundee University, UK
  • Ram Savan* (Cytokines 2025 Seattle Meeting Co-Chair), University of Washington, USA
  • Sandra Nicholson (2023-2026), The Walter & Eliza Hall Institute, Australia
  • Christoph Garbers (2023-2026), Institute of Clinical Biochemistry at Hannover Medical School, Germany
  • Estanislao Nistal Villan* (Cytokines 2029 Salamanca Meeting Co-Chair), Universidad CEU San Pablo, Madrid, Spain
  • Yoshiya Tanaka (2023-2026), University of Occupational and Environmental Health, Japan
  • Ivan Zanoni* (Cytokines 2028 Boston Meeting Chair), Boston Children’s Hospital, USA
  • Stephanie Flores, (ex-officio), ICIS Managing Director, San Francisco, USA

*Ex-Officio members by virtue of their position as future meeting Co-Chair.

Signals+ Editorial Board and Communications Committee

  • Daniella Schwartz (Co-Editor in Chief), University of Pittsburgh, USA
  • Di Yu (Co-Editor in Chief), Frazer Institute, University of Queensland, Australia
  • Saurabh Chattopadhyay, University of Toledo, USA 
  • Zhian (Anthony) Chen, Frazer Institute, University of Queensland, Australia
  • Mohamed Saad, South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia 
  • Maialen Sebastian-de la Cruz, Universidad del País Vasco / Euskal Herriko Unibertsitatea, España